United States Biotechnology & Medical Research

Track

Zyla Life Sciences (ZCOR)

Track

No insider activity signal

Not featured in screeners

Featured in screeners

No insider activity signal

Not featured in screeners

Ticker: ZCOR Exchange: OTC

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signals

0 activity signals detected for Zyla Life Sciences

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

Sale 30 Dec 2019

Value US$854,026.94 | Price 446.95 | Shares 3,651 (-19.9%)

Sale 23 Dec 2019

Value US$3,744,799.42 | Price 158.02 | Shares 54,022 (-1.6%)

Planned sale 2 Jan 2018

Value US$910.00 | Price 1.00 | Shares 910 (-2.4%)

Planned sale 2 Oct 2017

Value US$11,223.00 | Price 1.29 | Shares 8,700 (-41.9%)

Planned sale 2 Oct 2017

Value US$1,183.00 | Price 1.30 | Shares 910 (-2.3%)

Planned sale 3 Jul 2017

Value US$8,212.80 | Price 2.36 | Shares 3,480 (-7.6%)

Planned sale 3 Jul 2017

Value US$2,138.50 | Price 2.35 | Shares 910 (-2.3%)

Planned sale 3 Jul 2017

Value US$1,894.10 | Price 2.35 | Shares 806 (-2.7%)

Planned sale 30 Jun 2017

Value US$20,793.00 | Price 2.39 | Shares 8,700 (-29.5%)

Planned sale 3 Apr 2017

Value US$43,409.52 | Price 5.04 | Shares 8,613 (-15.8%)

Planned sale 3 Apr 2017

Value US$4,070.30 | Price 5.05 | Shares 806 (-2.7%)

Planned sale 31 Mar 2017

Value US$2,765.76 | Price 5.16 | Shares 536 (-2.9%)

Planned sale 31 Mar 2017

Value US$44,457.00 | Price 5.11 | Shares 8,700 (-22.8%)

Planned sale 20 Mar 2017

Value US$20,187.50 | Price 4.75 | Shares 4,250 (-10.0%)

Planned sale 3 Jan 2017

Value US$6,246.50 | Price 7.75 | Shares 806 (-2.6%)

Planned sale 3 Jan 2017

Value US$4,154.00 | Price 7.75 | Shares 536 (-2.8%)

Planned sale 3 Jan 2017

Value US$104,200.40 | Price 7.73 | Shares 13,480 (-19.8%)

Planned sale 30 Dec 2016

Value US$67,947.00 | Price 7.81 | Shares 8,700 (-18.6%)

Planned sale 3 Oct 2016

Value US$6,093.36 | Price 7.56 | Shares 806 (-2.6%)

Planned sale 3 Oct 2016

Value US$112,050.00 | Price 7.47 | Shares 15,000 (-6.0%)

Planned sale 3 Oct 2016

Value US$100,695.60 | Price 7.47 | Shares 13,480 (-16.5%)

Planned sale 30 Sep 2016

Value US$189,750.00 | Price 7.59 | Shares 25,000 (-34.8%)

Planned sale 30 Sep 2016

Value US$4,121.84 | Price 7.69 | Shares 536 (-2.7%)

Planned sale 30 Sep 2016

Value US$65,685.00 | Price 7.55 | Shares 8,700 (-10.8%)

Planned sale 6 Jul 2016

Value US$25,100.00 | Price 5.02 | Shares 5,000 (-2.0%)

Planned sale 5 Jul 2016

Value US$17,574.00 | Price 5.05 | Shares 3,480 (-4.1%)

Planned sale 5 Jul 2016

Value US$24,700.00 | Price 4.94 | Shares 5,000 (-1.9%)

Planned sale 1 Jul 2016

Value US$50,600.00 | Price 5.06 | Shares 10,000 (-10.5%)

Planned sale 1 Jul 2016

Value US$25,350.00 | Price 5.07 | Shares 5,000 (-1.9%)

Planned sale 30 Jun 2016

Value US$40,716.00 | Price 4.68 | Shares 8,700 (-9.7%)

Planned sale 30 Jun 2016

Value US$2,492.40 | Price 4.65 | Shares 536 (-2.6%)

Planned sale 5 Apr 2016

Value US$34,950.00 | Price 6.99 | Shares 5,000 (-1.9%)

Planned sale 5 Apr 2016

Value US$5,985.60 | Price 6.96 | Shares 860 (-2.5%)

Planned sale 4 Apr 2016

Value US$34,950.00 | Price 6.99 | Shares 5,000 (-1.8%)

Planned sale 1 Apr 2016

Value US$34,700.00 | Price 6.94 | Shares 5,000 (-1.8%)

Planned sale 1 Apr 2016

Value US$24,429.60 | Price 7.02 | Shares 3,480 (-3.5%)

Planned sale 31 Mar 2016

Value US$3,601.92 | Price 6.72 | Shares 536 (-2.6%)

Planned sale 31 Mar 2016

Value US$58,290.00 | Price 6.70 | Shares 8,700 (-8.9%)

Planned sale 11 Jan 2016

Value US$28,950.00 | Price 9.65 | Shares 3,000 (-1.1%)

Planned sale 8 Jan 2016

Value US$38,760.00 | Price 9.69 | Shares 4,000 (-1.4%)

Planned sale 7 Jan 2016

Value US$28,830.00 | Price 9.61 | Shares 3,000 (-1.0%)

Planned sale 6 Jan 2016

Value US$21,336.00 | Price 10.16 | Shares 2,100 (-0.7%)

Planned sale 5 Jan 2016

Value US$15,554.00 | Price 11.11 | Shares 1,400 (-0.5%)

Planned sale 4 Jan 2016

Value US$15,705.00 | Price 10.47 | Shares 1,500 (-0.5%)

Planned sale 4 Jan 2016

Value US$8,987.00 | Price 10.45 | Shares 860 (-2.4%)

Planned sale 4 Jan 2016

Value US$37,166.40 | Price 10.68 | Shares 3,480 (-3.4%)

Planned sale 31 Dec 2015

Value US$5,574.40 | Price 10.40 | Shares 536 (-2.5%)

Planned sale 31 Dec 2015

Value US$90,480.00 | Price 10.40 | Shares 8,700 (-8.2%)

Buy 11 Feb 2014

Value US$3,201,252.00 | Price 12.00 | Shares 266,771 (+36.0%)

Buy 11 Feb 2014

Value US$58,344.00 | Price 12.00 | Shares 4,862 (+23.1%)

Buy 11 Feb 2014

Value US$14,040.00 | Price 12.00 | Shares 1,170 (+8.2%)

Buy 11 Feb 2014

Value US$788,304.00 | Price 12.00 | Shares 65,692 (+8.2%)

Buy 11 Feb 2014

Value US$388,056.00 | Price 12.00 | Shares 32,338 (+8.2%)

Buy 11 Feb 2014

Value US$999,996.00 | Price 12.00 | Shares 83,333 (+36.0%)

Buy 11 Feb 2014

Value US$1,875,000.00 | Price 12.00 | Shares 156,250 (+8.4%)

Buy 11 Feb 2014

Value US$1,599,996.00 | Price 12.00 | Shares 133,333 (+7.7%)

Buy 11 Feb 2014

Value US$500,004.00 | Price 12.00 | Shares 41,667 (+2.0%)

Buy 11 Feb 2014

Value US$500,004.00 | Price 12.00 | Shares 41,667 (+2.0%)

Buy 11 Feb 2014

Value US$999,996.00 | Price 12.00 | Shares 83,333 (+36.0%)

Buy 11 Feb 2014

Value US$1,599,996.00 | Price 12.00 | Shares 133,333 (+7.7%)

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2020-01-10	2019-12-30	S Sale	Riva Ridge Capital Management LP	3,651 -19.9% 446.95 US$854,027	3,651 -19.9%	446.95	US$854,027
2020-01-10	2019-12-23	S Sale	Riva Ridge Capital Management LP	54,022 -1.6% 158.02 US$3,744,799	54,022 -1.6%	158.02	US$3,744,799
2018-01-03	2018-01-02	PlS Planned sale	Shea Patrick M Chief Commercial Officer Officer	50,521 -48.9% 131.53 US$4,507,612	50,521 -48.9%	131.53	US$4,507,612
2017-10-03	2017-10-02	PlS Planned sale	Strobeck Mark Chief Operating Officer	8,700 -41.9% 1.29 US$11,223	8,700 -41.9%	1.29	US$11,223
2017-10-03	2017-10-02	PlS Planned sale	Shea Patrick M Chief Commercial Officer	910 -2.3% 1.30 US$1,183	910 -2.3%	1.30	US$1,183
2017-07-06	2017-07-03	PlS Planned sale	Musial Stan Chief Financial Officer Officer	3,480 -7.6% 2.36 US$8,213	3,480 -7.6%	2.36	US$8,213
2017-07-06	2017-07-03	PlS Planned sale	Shea Patrick M Chief Commercial Officer Officer	910 -2.3% 2.35 US$2,138	910 -2.3%	2.35	US$2,138
2017-07-06	2017-07-03	PlS Planned sale	VARKI PAUL SVP, GC & Chief Compliance Off Officer	806 -2.7% 2.35 US$1,894	806 -2.7%	2.35	US$1,894
2017-07-05	2017-06-30	PlS Planned sale	Strobeck Mark Chief Operating Officer Officer	8,700 -29.5% 2.39 US$20,793	8,700 -29.5%	2.39	US$20,793
2017-04-05	2017-04-03	PlS Planned sale	Musial Stan Chief Financial Officer	8,613 -15.8% 5.04 US$43,410	8,613 -15.8%	5.04	US$43,410
2017-04-04	2017-04-03	PlS Planned sale	VARKI PAUL SVP, GC & Chief Compliance Off	806 -2.7% 5.05 US$4,070	806 -2.7%	5.05	US$4,070
2017-04-04	2017-03-31	PlS Planned sale	Dayno Jeffrey M. Chief Medical Officer	536 -2.9% 5.16 US$2,766	536 -2.9%	5.16	US$2,766
2017-03-31	2017-03-31	PlS Planned sale	Strobeck Mark Chief Operating Officer	8,700 -22.8% 5.11 US$44,457	8,700 -22.8%	5.11	US$44,457
2017-03-21	2017-03-20	PlS Planned sale	Shea Patrick M Chief Commercial Officer	4,250 -10.0% 4.75 US$20,188	4,250 -10.0%	4.75	US$20,188
2017-01-04	2017-01-03	PlS Planned sale	VARKI PAUL SVP, GC & Chief Compliance Off	806 -2.6% 7.75 US$6,246	806 -2.6%	7.75	US$6,246
2017-01-04	2017-01-03	PlS Planned sale	Dayno Jeffrey M. Chief Medical Officer	536 -2.8% 7.75 US$4,154	536 -2.8%	7.75	US$4,154
2017-01-04	2017-01-03	PlS Planned sale	Musial Stan Chief Financial Officer	13,480 -19.8% 7.73 US$104,200	13,480 -19.8%	7.73	US$104,200
2017-01-04	2016-12-30	PlS Planned sale	Strobeck Mark Chief Operating Officer	8,700 -18.6% 7.81 US$67,947	8,700 -18.6%	7.81	US$67,947
2016-10-04	2016-10-03	PlS Planned sale	VARKI PAUL SVP, GC & Chief Compliance Off Officer	806 -2.6% 7.56 US$6,093	806 -2.6%	7.56	US$6,093
2016-10-04	2016-10-03	PlS Planned sale	Radie Robert S President and CEO Executive Director	15,000 -6.0% 7.47 US$112,050	15,000 -6.0%	7.47	US$112,050
2016-10-04	2016-10-03	PlS Planned sale	Musial Stan Chief Financial Officer Officer	13,480 -16.5% 7.47 US$100,696	13,480 -16.5%	7.47	US$100,696
2016-10-03	2016-09-30	PlS Planned sale	Strobeck Mark Chief Operating Officer Officer	25,000 -34.8% 7.59 US$189,750	25,000 -34.8%	7.59	US$189,750
2016-10-03	2016-09-30	PlS Planned sale	Dayno Jeffrey M. Chief Medical Officer Officer	536 -2.7% 7.69 US$4,122	536 -2.7%	7.69	US$4,122
2016-10-03	2016-09-30	PlS Planned sale	Strobeck Mark Chief Operating Officer Officer	8,700 -10.8% 7.55 US$65,685	8,700 -10.8%	7.55	US$65,685
2016-07-06	2016-07-06	PlS Planned sale	Radie Robert S President and CEO Executive Director	5,000 -2.0% 5.02 US$25,100	5,000 -2.0%	5.02	US$25,100
2016-07-06	2016-07-05	PlS Planned sale	Musial Stan Chief Financial Officer Officer	3,480 -4.1% 5.05 US$17,574	3,480 -4.1%	5.05	US$17,574
2016-07-06	2016-07-05	PlS Planned sale	Radie Robert S President and CEO Executive Director	5,000 -1.9% 4.94 US$24,700	5,000 -1.9%	4.94	US$24,700
2016-07-06	2016-07-01	PlS Planned sale	Musial Stan Chief Financial Officer Officer	10,000 -10.5% 5.06 US$50,600	10,000 -10.5%	5.06	US$50,600
2016-07-06	2016-07-01	PlS Planned sale	Radie Robert S President and CEO Executive Director	5,000 -1.9% 5.07 US$25,350	5,000 -1.9%	5.07	US$25,350
2016-07-05	2016-06-30	PlS Planned sale	Strobeck Mark Chief Business Officer Officer	8,700 -9.7% 4.68 US$40,716	8,700 -9.7%	4.68	US$40,716
2016-07-05	2016-06-30	PlS Planned sale	Dayno Jeffrey M. Chief Medical Officer Officer	536 -2.6% 4.65 US$2,492	536 -2.6%	4.65	US$2,492
2016-04-06	2016-04-05	PlS Planned sale	Radie Robert S President and CEO Executive Director	5,000 -1.9% 6.99 US$34,950	5,000 -1.9%	6.99	US$34,950
2016-04-06	2016-04-05	PlS Planned sale	Melloy Deanne F. Chief Commercial Officer Officer	860 -2.5% 6.96 US$5,986	860 -2.5%	6.96	US$5,986
2016-04-05	2016-04-04	PlS Planned sale	Radie Robert S President and CEO Executive Director	5,000 -1.8% 6.99 US$34,950	5,000 -1.8%	6.99	US$34,950
2016-04-05	2016-04-01	PlS Planned sale	Radie Robert S President and CEO Executive Director	5,000 -1.8% 6.94 US$34,700	5,000 -1.8%	6.94	US$34,700
2016-04-04	2016-04-01	PlS Planned sale	Musial Stan Chief Financial Officer Officer	3,480 -3.5% 7.02 US$24,430	3,480 -3.5%	7.02	US$24,430
2016-04-04	2016-03-31	PlS Planned sale	Dayno Jeffrey M. Chief Medical Officer Officer	536 -2.6% 6.72 US$3,602	536 -2.6%	6.72	US$3,602
2016-04-04	2016-03-31	PlS Planned sale	Strobeck Mark Chief Business Officer Officer	8,700 -8.9% 6.70 US$58,290	8,700 -8.9%	6.70	US$58,290
2016-01-12	2016-01-11	PlS Planned sale	Radie Robert S President and CEO Executive Director	3,000 -1.1% 9.65 US$28,950	3,000 -1.1%	9.65	US$28,950
2016-01-12	2016-01-08	PlS Planned sale	Radie Robert S President and CEO Executive Director	4,000 -1.4% 9.69 US$38,760	4,000 -1.4%	9.69	US$38,760
2016-01-12	2016-01-07	PlS Planned sale	Radie Robert S President and CEO Executive Director	3,000 -1.0% 9.61 US$28,830	3,000 -1.0%	9.61	US$28,830
2016-01-07	2016-01-06	PlS Planned sale	Radie Robert S President and CEO Executive Director	2,100 -0.7% 10.16 US$21,336	2,100 -0.7%	10.16	US$21,336
2016-01-07	2016-01-05	PlS Planned sale	Radie Robert S President and CEO Executive Director	1,400 -0.5% 11.11 US$15,554	1,400 -0.5%	11.11	US$15,554
2016-01-07	2016-01-04	PlS Planned sale	Radie Robert S President and CEO Executive Director	1,500 -0.5% 10.47 US$15,705	1,500 -0.5%	10.47	US$15,705
2016-01-05	2016-01-04	PlS Planned sale	Melloy Deanne F. Chief Commercial Officer Officer	860 -2.4% 10.45 US$8,987	860 -2.4%	10.45	US$8,987
2016-01-05	2016-01-04	PlS Planned sale	Musial Stan Chief Financial Officer Officer	3,480 -3.4% 10.68 US$37,166	3,480 -3.4%	10.68	US$37,166
2016-01-05	2015-12-31	PlS Planned sale	Dayno Jeffrey M. Chief Medical Officer Officer	536 -2.5% 10.40 US$5,574	536 -2.5%	10.40	US$5,574
2016-01-05	2015-12-31	PlS Planned sale	Strobeck Mark Chief Business Officer Officer	8,700 -8.2% 10.40 US$90,480	8,700 -8.2%	10.40	US$90,480
2014-02-13	2014-02-11	B Purchase	Index Venture Associates III Ltd Large shareholder	266,771 +36.0% 12.00 US$3,201,252	266,771 +36.0%	12.00	US$3,201,252
2014-02-13	2014-02-11	B Purchase	Index Venture Associates III Ltd Large shareholder	4,862 +23.1% 12.00 US$58,344	4,862 +23.1%	12.00	US$58,344
2014-02-13	2014-02-11	B Purchase	Index Venture Associates III Ltd Large shareholder	1,170 +8.2% 12.00 US$14,040	1,170 +8.2%	12.00	US$14,040
2014-02-13	2014-02-11	B Purchase	Index Venture Associates III Ltd Large shareholder	65,692 +8.2% 12.00 US$788,304	65,692 +8.2%	12.00	US$788,304
2014-02-13	2014-02-11	B Purchase	Danish Biotech SPV I P/S Large shareholder	83,333 +36.0% 12.00 US$999,996	83,333 +36.0%	12.00	US$999,996
2014-02-13	2014-02-11	B Purchase	Danish Biotech SPV I P/S Large shareholder	156,250 +8.4% 12.00 US$1,875,000	156,250 +8.4%	12.00	US$1,875,000
2014-02-13	2014-02-11	B Purchase	Index Venture Associates III Ltd Large shareholder	32,338 +8.2% 12.00 US$388,056	32,338 +8.2%	12.00	US$388,056
2014-02-12	2014-02-11	B Purchase	SEGERROS ANDREAS Rutger Non-Executive Director Large shareholder	133,333 +7.7% 12.00 US$1,599,996	133,333 +7.7%	12.00	US$1,599,996
2014-02-12	2014-02-11	B Purchase	FORMELA JEAN FRANCOIS Non-Executive Director Large shareholder	41,667 +2.0% 12.00 US$500,004	41,667 +2.0%	12.00	US$500,004
2014-02-12	2014-02-11	B Purchase	Atlas Venture Fund VII L P Large shareholder	41,667 +2.0% 12.00 US$500,004	41,667 +2.0%	12.00	US$500,004
2014-02-12	2014-02-11	B Purchase	AGUIAR-LUCANDER RENEE Non-Executive Director	83,333 +36.0% 12.00 US$999,996	83,333 +36.0%	12.00	US$999,996
2014-02-12	2014-02-11	B Purchase	SUNSTONE LIFE SCIENCE VENTURES FUND II K/S Large shareholder	133,333 +7.7% 12.00 US$1,599,996	133,333 +7.7%	12.00	US$1,599,996